▲ +20.20% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Trulieve Cannabis in the last 3 months. The average price target is $59.50, with a high forecast of $107.00 and a low forecast of $23.00. The average price target represents a 20.20% upside from the last price of $49.50.
The current consensus among 9 polled investment analysts is to buy stock in Trulieve Cannabis.
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, and Connecticut, as well as directly to patients through home delivery. It produces approximately 155 stock keeping units, including smokable flower, flower pods for vaporizing, concentrates, topicals, capsules, tinctures, and vape cartridges. As of December 29, 2020, the company operated through 75 dispensaries in the United States. Trulieve Cannabis Corp. is headquartered in Quincy, Florida.